7th TPD & Induced Proximity Summit

Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address Unmet Need in Oncology & Beyond

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck US and KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets, it has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based conference, returning to Downtown Boston, October 28 – 31, 2024.

See what’s in store in the Full Event Guide.

Spanning foundational research and discovery, through to IND-filing and clinical trials, this is the world’s definitive meeting to discuss opportunities and challenges the TPD & Induced Proximity field must address to expand the target space and facilitate the discovery and development of therapeutically relevant degraders, blockers, stabilizers and inducers of protein-protein interactions. Whether you’re entering the TPD & Induced Proximity space for the first time or a well-seasoned TPD veteran, this forum will equip you with the knowhow and connections to make rapid advances in your work.

Assembling over 550 TPD & Induced Proximity enthusiasts from across every corner of the landscape, we have left no stone unturned in our duty to continue to deliver the full breadth and depth of protein degradation and modulation research with SureTACs, EpiTACs, RIPTACs, Molecular Gates, and so much more.

The 7th TPD & Induced Proximity Summit is the field’s singular, one-stop-shop to gain unparalleled overview of cutting-edge R&D, whilst diving deep into end-to-end development strategy to propel degraders towards the first clinical approval.

Dates: October 28 – 31
Location: The Westin Copley Place, Boston, MA
Event Program: https://ter.li/ejyp6d